Novartis announces FDA approval for Jadenu™ to simplify …
https://www.novartis.com/us-en/news/media-releases/novartis-announces-fda-approval-jadenutm-simplify-treatment-administration-patients-chronic-iron-overload
WEBMar 31, 2015. - Jadenu (deferasirox), a new formulation of Exjade (deferasirox), is the only once-daily oral tablet for iron chelation. - Jadenu, taken with or without food, simplifies daily treatment administration for patients with chronic iron overload. - Chronic iron overload is a serious condition that can affect people with sickle cell ...
DA: 41 PA: 16 MOZ Rank: 52